Key result
Early CV risk assessment and lifestyle modification starting at age 20 optimize female cardiovascular prevention.
Why the study?
Cardiovascular mortality rates have stagnated among younger women compared with younger men, highlighting the need for earlier preventive strategies.
This review emphasizes the critical need to initiate cardiovascular risk assessment and preventive strategies earlier in women, starting at age 20, to address the stagnation of cardiovascular mortality rates in younger women.
May support earlier CV risk assessment from age 20 in women; leaves open prospective outcome confirmation in trials.
Over the past decades, progress in efforts to reduce cardiovascular morbidity and mortality has been achieved, although a disturbing trend for stagnation of cardiovascular mortality rates among younger women compared with those in younger men has been identified. While the menopause transition has traditionally offered an unequivocal opportunity to assess cardiovascular risk and counsel women to adopt preventive strategies, the veritable 'window of opportunity', usually applied to the concept of timing the initiation of menopausal hormone therapy, must be opened much wider to encompass younger women including those who have experienced adverse events during pregnancy, treatment for breast cancer, and premature menopause. Collaborative efforts by a number of expert medical groups provide encouragement and justification for an aggressive approach to identify and modify cardiovascular risk earlier in younger women, starting at age 20 years. Quantifying cardiovascular risk with country and population-specific risk calculators can be helpful to validate perception of risk and encourage preventive recommendations. Adherence to established guidelines for lifestyle measures (smoking cessation, healthful eating habits, enhanced physical activity, and weight control) along with treatment of traditional risk factors - hypertension, glucose intolerance, and dyslipidemia - provides a sound basis for prevention of cardiovascular disease in women.
No takes yet. Share an insight, caveat, or question.
Cynthia A. Stuenkel (2019) conducted a review in Cardiovascular disease in women. Preventive strategies (lifestyle measures and risk factor treatment) was evaluated. Early identification and modification of cardiovascular risk in women, starting at age 20, along with adherence to lifestyle measures and risk factor treatment, are essential for disease prevention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: